July 06, 2009
Home
About
Submit Press Release
PR Firms
Editors/Journalists
Search Archives
 
News Releases by Category  
News by Country  
News by MSA  
All News for Today  
Browse News by Day  
News by Trackbacks  
All Press Releases for September 19, 2006 Subscribe to this News Feed  
 

Pfizer Goes to Court to Stop ‘The Whistleblower — Confessions of a Healthcare Hitman’

Download this press release as an Adobe PDF document.

Dr. Peter Rost, author of “The Whistleblower — Confessions of a Healthcare Hitman,” today revealed that Pfizer has asked the US District Court, NY, to advise on relief and for sanctions against Dr. Rost for writing “The Whistleblower,” per recently released court records, case no. 05-CV-10384.
a scathing account of the allegedly 'insidious' practices of the industry that once paid (Dr. Rost’s) salary and of the US healthcare system. The media is sure to lap it up.

New York, NY (PRWEB) September 19, 2006 – Dr. Peter Rost , author of “The Whistleblower — Confessions of a Healthcare Hitman,” today revealed that Pfizer has asked the US District Court, NY, to advise on relief and for sanctions against Dr. Rost for writing “The Whistleblower,” per recently released court records, case no. 05-CV-10384. (Court transcript attached.)

TheWhistleblowerConfessionsofaHealthcareHitman.jpg

In a separate legal communiqué, Pfizer’s lawyer writes, “Be advised that we are in the process of evaluating the extent to which this book likewise violates the Protective Order.” Pfizer has also requested “Confidential” designation of virtually all documents used to write “The Whistleblower.”

“Pfizer’s attempt to stop ‘The Whistleblower’ and deny the public the right to view associated documents may not be surprising considering the explosive content and Pfizer’s infamous history as the only drug company forced by the government to sign not just one, but two separate Corporate Integrity Agreements,” said Dr. Rost.

The New York Post wrote the following review, “A drug company executive is about to blow the lid off the pharmaceutical industry . . . revealing everything from sex in the corner office to private investigators spying on employees, company phone surveillance, FBI investigations and financial shenanigans resulting in million-dollar payouts.”

And L Magazine stated, “In this Enron-esque exposé of the healthcare industry, an . . . executive reveals everything you should already be assuming about most multinational corporations. You know, greed, spying, million-dollar payouts, and sex in the corner office.”

Medical Marketing & Media, a drug industry publication, concluded that “The Whistleblower” is “a scathing account of the allegedly 'insidious' practices of the industry that once paid (Dr. Rost’s) salary and of the US healthcare system. The media is sure to lap it up.”

Soft Skull Press sold the entire first printing during the first day of sale, September 10, 2006.

For more information on “The Whistleblower,” sample pages, news, reviews, and the “Whistleblower Video,” go to: http://the-whistleblower-by-peter-rost.blogspot.com/

Dr. Peter Rost daily blog: http://peterrost.blogspot.com/

Contact: Kristin Pulkkinen, Publicity Director, Soft Skull Press, (718) 643-1599

# # #

Trackback URL: http://www.prweb.com/pingpr.php/RW1wdC1NYWduLVNxdWEtSG9yci1JbnNlLVplcm8=


See the original story at: http://www.prweb.com/releases/2006/09/prweb439408.htm
Other Releases by this Member
Email this story to a colleague
Printer Friendly Version
Bookmark with del.icio.us
Bookmark with Y!MyWeb
Submit to Digg
Kristin Pulkkinen
Soft Skull Press
718-643-1599
Email us Here

Court transcript case no. 05-CV-10384
Uploaded: Sep 18, 2006
File Name: CourtTranscript.jpg

Pfizer legal communiqué
Uploaded: Sep 18, 2006
File Name: Sep11LetterEBG.pdf

If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these release. Our complete disclaimer appears here.
 
Disclaimer: If you have any questions regarding information in these press releases please contact the company listed in the press release.
Please do not contact PRWeb®. We will be unable to assist you with your inquiry.
PRWeb® disclaims any content contained in these releases. Our complete disclaimer appears here.

© Copyright 1997-2007, Vocus PRW Holdings, LLC.
Vocus, PRWeb and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

Terms of Service | Privacy Policy | Copyright